Abstract: Sinus histiocytosis with massive lymphadenopathy
S
inus histiocytosis with massive lymphadenopathy, or Rosai-Dorfman disease (RDD), is a rare nonneoplastic histiocytic disorder that in its most typical form presents with painless massive cervical lymphadenopathy, which is caused by accumulation of lymphocytes and histiocytes distending the lymph node sinuses. The architecture of the lymph node is preserved, and the individual histiocytes contain intact lymphocytes or, less commonly, other cells in the cytoplasm, a phenomenon known as emperipolesis, which is distinctive of the disease. 1 It typically affects young adults and adolescents, although any age group can be affected, and it appears to have a higher incidence among people of African descent. 1 Its course is unpredictable, but it is generally indolent, with alternating episodes of worsening and resolving of symptoms. 1 The outcome is usually good, and the disease is often self-limited, with little evidence that treatment other than surgery in selected patients plays any role. 1, 2 Although most patients present with nodal disease, extranodal involvement is a common feature of RDD and may occur in more than 40% of patients. Almost any system can be affected, and nodal disease is not always present, expanding the clinical spectrum of the disorder. 1 The disease has a predilection for the tissues of the head and neck, and 10% to 20% of patients have involvement of the upper aerodigestive tract, including the nasal and oral cavities, and the paranasal sinuses. 1, 3 Less frequent (5-10%) is involvement of the orbits or the central nervous system. The rarity of the disease and the uncommon isolated extranodal presentation together create a diagnostic challenge. We describe three patients with RDD with exclusive extranodal involvement, highlighting the diversity of clinical presentation of this disease.
CASE REPORTS

Patient 1
A 6-year-old African-American girl presented with a 1-year history of progressive swelling of her right orbit and proptosis and blindness of the right eye. Her past medical history was significant for a massive right cervical lymphadenopathy that had been excised at 4 years of age and was thought to be reactive. Imaging studies showed a mass originating in her right orbit and extending into the right sphenoid bone and cavernous sinus, and into the right temporal bone (Fig. 1A ). An enucleation of the right eye and gross resection of the orbital mass was performed. Microscopic sections of the lesion showed histologic features diagnostic of RDD. The residual tumor progressed after surgery, with protrusion of tumor beyond the eyelids and intracranial extension into the left side of the cavernous sinus. A short course of steroid therapy was ineffective, and the patient received 30 Gy external beam radiation therapy, with a marked decrease in the size of the mass. She remained stable for 24 months, when progression of the disease was documented. A 2-month course of prednisone (2 mg/kg/d) was given, resulting in a slight decrease in the size of the residual mass. The disease remained stable for 7 years, when it was found to have progressed with occlusion of the right internal carotid artery. The patient was then started on weekly vinblastine (5 mg/m 2 ) and methotrexate (30 mg/m 2 ), with a slight decrease in the size of the tumor. Treatments were given weekly for 6 months, and then on alternate weeks for 6 additional months. However, 6 months after stopping therapy, she presented with severe headaches and signs of disease progression by imaging. On this occasion, the patient received two courses of 2-chlorodeoxyadenosine (2-CdA; 5 mg/m 2 /d × 5 consecutive days). There was symptomatic improvement, although no change in the size of the tumor was subsequently documented. She has been asymptomatic with stable intracranial and intraorbital disease for 30 months (see Fig. 1B ).
Patient 2
A 15-year-old African-American girl presented with a short history of severe fronto-orbital headache, without visual disturbances or emesis. Her past medical history was unremarkable. Neuroimaging studies disclosed the presence of multiple well-defined enhancing lesions in the anterior and posterior falx, without extension into the brain parenchyma. The clinical diagnosis of multiple meningiomas was made, and the patient was started on dexamethasone, with little improvement. A craniotomy was performed eventually, with excision of one of the lesions. Microscopic sections of the lesion showed fibrous tissue with an intense inflammatory infiltrate composed of histiocytes, lymphocytes, and plasma cells. Multiple histiocytes contained within the cytoplasm intact lymphocytes (emperipolesis) (Fig. 2) . No distinctive meningothelial component was seen. A RDD diagnosis was established. She received dexamethasone for 4 months but continued to show disease progression, with intense headache and the development of intense orbital pain and left proptosis. The patient was then referred to our institution. On physical examination, there was evidence of left proptosis and limitation of the upward movement of the left eye, but vision was not compromised. There were no palpable lymph nodes, and the spleen was palpable 5 cm below the left costal margin. Laboratory evaluation was significant only for mild microcytic hypochromic anemia (hemoglobin 10.1 g/dL, mean corpuscular volume 72.2 fl). Epstein-Barr virus (EBV) serology showed positivity for IgM against nuclear (NA) and viral capsid (VCA) antigens, consistent with recent infection. Magnetic resonance imaging of the brain and orbits showed multiple enhancing lesions in the anterior and posterior falx and in both orbits, with associated proptosis of the left globe. The left optic nerve was encased by the mass. The lesions were isointense to gray matter on T1-weighted and T2-weighted images (Fig. 3) . A gallium scan showed markedly increased uptake by an enlarged spleen and mildly increased uptake in the mediastinum. A computed tomography scan confirmed enlarged mediastinal lymph nodes. There was no increased uptake of gallium by the intracranial or the intraorbital lesions. A biopsy of the left intraorbital mass was performed and confirmed the diagnosis of RDD. In situ hybridization for EBER failed to show any evidence of EBV genome in the histologic specimen. The patient had an acute EBV infection, unrelated to RDD. Follow-up in subsequent months showed a progressive decrease in the size of the spleen and mediastinal lymph nodes, but she continued to have severe headaches and orbital pain. Because of the extension of her disease and the prior lack of response to steroid therapy, treatment with 2-CdA was administered. She received three courses of 2-CdA ( 
Patient 3
A 9-year-old African-American girl presented with swelling and tenderness in the left frontal bone. X-ray showed a well-defined lytic lesion suggestive of eosinophilic granuloma. A skeletal survey did not show additional lesions. Surgical intervention with resection and curettage of the lesion was performed. Pathology showed granulation tissue with intense acute and chronic inflammation and multiple associated macrophages. CD1a stains were negative. The final diagnosis was unclear, and no additional treatment was given. Repeat x-rays performed in the subsequent 2 years failed to show any new lesions. Four years after the initial diagnosis, the patient sustained minor head trauma, and a repeat x-ray was performed. Three new well-defined small lytic lesions without sclerotic margins were noted in the skull (Fig. 4A) . However, the patient was asymptomatic, and physical examination showed no palpable skull lesions or tenderness and no lymphadenopathy. The skeletal survey did not show any additional lesions. Magnetic resonance imaging of the head showed a 
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Extranodal Rosai-Dorfman Disease slightly abnormally thickened infundibulum and absence of the normal posterior bright spot (see Fig. 4B ). The patient did not have evidence of diabetes insipidus or other neuroendocrine deficits. Laboratory evaluation was unremarkable. A review of the original histologic specimen disclosed intense histiocytic proliferation, with intense positivity for CD68 and S-100 and evidence of emperipolesis, diagnostic of RDD. The patient did not receive any treatment; she has remained asymptomatic and the skull lesions have been stable for 12 months.
DISCUSSION
We have presented three cases of exclusively extranodal RDD in which the unique clinical presentations posed a diagnostic challenge. The three cases developed in the head and neck area, and the clinical features mimicked other more common diseases such as sarcoma, inflammatory pseudotumor, meningioma, or Langerhans cell histiocytosis (LCH). Given the self-limited course in most patients with this disease, it is likely that extranodal RDD is underdiagnosed.
Intracranial involvement by RDD usually occurs in the form of a subarachnoid, subdural, or epidural mass in the convexity or in the suprasellar, parasagittal, or petroclival regions, causing headaches or, less commonly, seizures and hearing or vision loss. Less frequently, the lesions are intraspinal, and patients present with acute neurologic deficits. RDD with central nervous system involvement has been reported to have a predilection for older males, usually in the fourth decade, but as shown in this series it may be common in children as well. Since nodal involvement is infrequent in these cases, the diagnosis of meningioma is usually made. [4] [5] [6] Signal characteristics and enhancement patterns can be very similar to meningioma, with iso-or hypointense signal on T2-weighted images, perhaps reflecting both the tumor's hypercellularity and the presence of fibrosis. 7 In one of our patients (patient 3), the disease presented with recurrent lytic lesions in the skull, with no intra-or extracranial soft tissue or nodal disease. Skeletal involvement in RDD is rare (<5% of the reported cases), although it appears to be more prevalent in children. 8 Bone lesions are usually multiple, occur in long bones or skull, and have a lytic appearance. 8 The radiographic appearance of the lesions is very similar to that of LCH. However, as shown in one of our patients, RDD lesions differ from LCH lesions in that during the healing process, they lack the typical sclerotic border; instead they have fuzzy borders, and they resolve without eliciting sclerosis. 8 The histologic diagnosis of the bone lesions may be difficult, since lesions may have intense fibrosis and emperipolesis is much less conspicuous. Involvement of the hypotha- lamic-pituitary system by LCH is very well known. Patients usually present with diabetes insipidus, and other neuroendocrine deficits are also found. In those patients, magnetic resonance imaging usually shows infundibular thickening and lack of the posterior pituitary bright signal. 9 Infundibular thickening and diabetes insipidus in children are also found in other conditions, such as germinomas. However, the cause of the thickened pituitary stalk causing diabetes insipidus is not known in 50% to 60% of the children. 9 As illustrated by one of our patients, RDD can also infiltrate the infundibulum, an event that to our knowledge has not been reported previously. In our patient, however, the imaging findings have not correlated with neuroendocrine deficits.
The histologic features of extranodal RDD are very similar to its nodal counterpart, although lesions tend to be more fibrotic, with fewer typical histiocytes and less emperipolesis. 1, 8, 10 Thus, when the disease is predominantly extranodal, a pathologic diagnosis can still be made, but there is a greater likelihood of overlooking RDD in favor of nonspecific chronic inflammation, as occurred in one of our patients. In particular, the distinction from inflammatory pseudotumor is often difficult. Inflammatory pseudotumor may have a similar presentation with involvement of the head and neck, including orbital and intracranial spaces. 11, 12 The histologic features of both entities may overlap, with a proliferation of histiocytes and a lymphoplasmacytic inflammatory response. 13, 14 In fact, lesions characteristic of both entities may coexist in the same specimen. 13 Some authors have proposed that the two conditions indicate the ends of a continuum, with RDD representing an early stage of inflammatory response to an infective or inflammatory stimulus, and the inflammatory pseudotumor the late stage, after the loss of the inflammatory stimulus allows the differentiation of cells into fibroblasts and myofibroblasts. 13 Alternatively, aberrant cytokine expression within an inflammatory pseudotumor may result in local transformation of histiocytes into RDD cells. 13 The immunophenotype of the histiocytes of RDD has been well characterized. These histiocytes typically are positive for S-100 and have the characteristics of activated macrophages 3,10 rather than dendritic lineage features. They express monocyte/macrophage lineage-specific antigens such as CD14, CD68, and KiM1P, and antigens unique to activated macrophages such as MRP8 and MRP14. 13 Further, in situ hybridization studies have shown that these cells express c-fms. 10 Histiocytes and medium-sized monocytes coexist in the typical RDD lesions, 5, 10, 13 suggesting a cytokine-mediated mechanism by which immigrating monocytes are activated and result in histiocytic accumulation. Molecular studies using polymorphic regions of human androgen receptor locus have shown that the histiocytic proliferation is polyclonal, confirming the reactive nature of the disease. 15 The functional activation of the monocyte-macrophage system may be secondary to different stimuli, and a single pathogenic mechanism has not been described. Patients often present with mild anemia, polyclonal hypergammaglobulinemia, and an elevated erythrocyte sedimentation rate. 1 In one of our patients there was evidence of a recent EBV infection. In fact, serologic evidence of a past EBV infection is not uncommon in patients with RDD.
1 However, as shown in patient 2, the histiocytes of the lesion do not contain EBV DNA. 16 The clinical course of the disease is usually self-limited, although it may be chronic, with alternating episodes of worsening and relieving of symptoms. Over 70% to 80% of the patients have spontaneous responses and resolution of the symptoms, although most of them have persistent, stable disease.
1,2 Surgery is indicated when nodal or extranodal lesions compromise vital organs. The role of additional therapies, such as chemotherapy or radiation therapy, is minimal. Responses to chemotherapy have been documented, including the combination of alkylating agents with vincristine and steroids 2 and the combination of methotrexate and vinblastine.
2,17 One of our patients had stabilization of her disease for over 1 year with the latter combination, and another responded to the combination of prednisone and vinblastine. However, these anecdotal good responses to chemotherapy do not allow meaningful conclusions regarding their value. Similarly, as shown in one of our patients, occasional response to radiation therapy may occur. Doses greater than 20 to 30 Gy appear to be necessary to induce response, 18 contrasting with the much lower doses usually required for the treatment of LCH. Two of our patients had severe symptoms from significant intracranial disease that was not amenable to surgical intervention. Because of recent experience with 2-CdA in the treatment of recurrent LCH, and given the similarity of the cell of origin, we elected to treat two patients with recurrent disease with 2-CdA, a purine analog resistant to the enzyme adenosine deaminase (ADA) but not to deoxycytidine kinase (dCk). Normal mature lymphocytes and monocytes express high levels of dCk and therefore accumulate higher intracellular levels of 2-CdA. In vitro studies have shown that 2-CdA is a highly selective anti-monocyte agent that causes decreased monocyte function and viability and decreased IL-6 secretion. 19 Because tissue histiocytes are derived from the same stem cells as circulating monocytes, 2-CdA may be a good agent for the treatment of patients with histiocytic disorders. Studies have shown excellent results in children with recurrent or refractory LCH. 20 However, in the two patients with RDD treated with 2-CdA, no objective responses were obtained, although symptomatic improvement was seen in both.
In summary, exclusively extranodal presentation of RDD in children may represent a diagnostic challenge, and a high level of suspicion for this diagnosis is required. Of particular interest is its presentation in the tissues of the head and neck; RDD must be included in the differential diagnosis of bone lytic lesions and of orbital and intracranial tumors.
